Clinical Trial Update: Comparing Post-Op Narcotic Usage in Patients Receiving Periarticular Exparel vs. Standard Periarticular Joint Inj [Phase 4]

View source ↗

Summary

Phase 4 trial comparing post-operative narcotic usage in knee replacement patients receiving Exparel (bupivacaine liposome injectable suspension) versus standar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Exparel (liposomal bupivacaine)
• Standard periarticular joint injection (unspecified)

Snippet

Sponsor: University of California, Irvine | Conditions: Arthroplasty, Replacement, Knee | Phase 4 | Status: COMPLETED | Results posted: 2017-07-07